Anemia of Chronic Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-09-20
Clinical Trial Update: Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis [Phase 2]
Open-label extension safety study of PROCRIT (epoetin alfa) in anemia of chronic disease due to rheumatoid arthritis has been withdrawn.